Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Turnstone Biologics Corp. (TSBX) had Weighted-Average Shares Outstanding (Diluted) of 23.04M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-70.84M |
|
-- |
|
-- |
|
$72.49M |
|
$-72.49M |
|
$1.69M |
|
$-70.80M |
|
$-70.80M |
|
$-70.84M |
|
$-70.84M |
|
$-70.84M |
|
$-70.84M |
|
$-72.49M |
|
$-72.52M |
|
23.04M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
23.04M |
$-3.07 |
|
$-3.07 |
|
| Balance Sheet Financials | |
$34.22M |
|
$4.17M |
|
$5.92M |
|
$40.14M |
|
$8.20M |
|
-- |
|
$0.47M |
|
$8.67M |
|
$31.47M |
|
$31.47M |
|
$31.47M |
|
23.14M |
|
| Cash Flow Statement Financials | |
$-67.44M |
|
$78.56M |
|
$0.01M |
|
$17.91M |
|
$29.04M |
|
$11.13M |
|
$3.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-67.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-225.12% |
|
-225.12% |
|
-176.48% |
|
-225.12% |
|
$1.36 |
|
$-2.94 |
|
$-2.93 |
|